Sharon Choe is a senior executive with extensive experience in investor relations and business development across multiple sectors, including biotechnology and healthcare. Currently, Sharon serves as Head of Investor Relations at 3Daughters and Managing Director at Sable Therapeutics, where they focus on innovative approaches to healthcare solutions. Previously, Sharon held leadership roles at UBS Asset Management and Credit Suisse, among others, and was involved in high-stakes fundraising for a prestigious $14 billion company portfolio. Sharon earned a Bachelor of Science degree from Northeastern University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices